Jazz Pharmaceuticals Ii competitive analysis

Latest publications and patents of Jazz Pharmaceuticals Ii New

Explore the latest publications and patents granted to Jazz Pharmaceuticals Ii, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Jazz Pharmaceuticals Ii

Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl CarbamateGranted And Under Opposition
Jan 18, 2023Pegylated L-AsparaginasePatent Maintained As Amended
Nov 9, 2022Formulations Of (RGranted And Under Opposition

Explore Jazz Pharmaceuticals Ii's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl Carbamate1
Jan 18, 2023Pegylated L-Asparaginase1
Nov 9, 2022Formulations Of (R1

Latest PTAB cases involving Jazz Pharmaceuticals Ii

Discover the latest PTAB cases involving Jazz Pharmaceuticals Ii, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Jazz Pharmaceuticals Ii with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
JAZZ PHARMACEUTICALS II - 1 - - Non-Active
MATHYS & SQUIRE49 - - - Highly Aggressive